| Dr Gregory A Zittel, MD | |
|
719 Rodel Cv Ste 1015, Lake Mary, FL 32746-5716 | |
| (407) 302-3133 | |
| (407) 330-4690 |
| Full Name | Dr Gregory A Zittel |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 719 Rodel Cv Ste 1015, Lake Mary, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003807082 | NPI | - | NPPES |
| 379946800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | ME67849 (Florida) | Secondary |
| 207V00000X | Obstetrics & Gynecology | ME67849 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.
A pooled analysis of 11 previously published trials provides evidence that drug-eluting stents (DES)—increasingly used in coronary angioplasty—have benefits over bare-metal stents (BMS) by reducing the need for later revascularisation and reducing the risk of cardiac events
› Verified 1 days ago
| Entity Name | Physician Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137280 PECOS PAC ID: 0244135093 Enrollment ID: O20031204000591 |
News Archive
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.
A pooled analysis of 11 previously published trials provides evidence that drug-eluting stents (DES)—increasingly used in coronary angioplasty—have benefits over bare-metal stents (BMS) by reducing the need for later revascularisation and reducing the risk of cardiac events
› Verified 1 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.
A pooled analysis of 11 previously published trials provides evidence that drug-eluting stents (DES)—increasingly used in coronary angioplasty—have benefits over bare-metal stents (BMS) by reducing the need for later revascularisation and reducing the risk of cardiac events
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory A Zittel, MD 719 Rodel Cv Ste 1015, Lake Mary, FL 32746-5716 Ph: (407) 302-3133 | Dr Gregory A Zittel, MD 719 Rodel Cv Ste 1015, Lake Mary, FL 32746-5716 Ph: (407) 302-3133 |
News Archive
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.
A pooled analysis of 11 previously published trials provides evidence that drug-eluting stents (DES)—increasingly used in coronary angioplasty—have benefits over bare-metal stents (BMS) by reducing the need for later revascularisation and reducing the risk of cardiac events
› Verified 1 days ago
Dr. George Patounakis, M.D, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 400 Colonial Center Pkwy, Suite 150, Lake Mary, FL 32746 Phone: 407-804-9670 Fax: 407-804-9671 | |
Sonia R Enriquez, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 731 Stirling Center Pl Unit 1931, Lake Mary, FL 32746 Phone: 407-436-7375 Fax: 407-986-9007 | |
David L Goss, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 785 Primera Blvd Ste 1031, Lake Mary, FL 32746 Phone: 407-834-8111 Fax: 407-708-1958 | |
Dr. Edmund C.a. Boulting, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 785 Primera Blvd, Suite 1031, Lake Mary, FL 32746 Phone: 407-834-8111 Fax: 407-708-1958 | |
Mr. John V Parker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 785 Primera Blvd, Suite 1031, Lake Mary, FL 32746 Phone: 407-834-8111 Fax: 407-708-1958 | |
Jessica Monique Covington, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 785 Primera Blvd Ste 1031, Lake Mary, FL 32746 Phone: 407-834-8111 Fax: 407-834-8506 |